209 related articles for article (PubMed ID: 3044273)
61. [Prophylactic effect of fosfomycin on CDDP nephrotoxicity].
Yogi S; Ikeuchi T; Kai Y
Hinyokika Kiyo; 1989 Apr; 35(4):615-21. PubMed ID: 2735267
[TBL] [Abstract][Full Text] [Related]
62. [Cisplatin nephrotoxicity: effects on fractional excretion of sodium and enzymuria].
Cirami C; Bianchi AM; Galigani P; Gadducci A; Colombi L; Facchini V; Palla R
Minerva Med; 1990; 81(1-2):79-86. PubMed ID: 1969127
[TBL] [Abstract][Full Text] [Related]
63. [Clinical significance of urinary enzymes in diabetes mellitus].
Morita E; Kaizu K; Uriu K; Eto S
J UOEH; 1990 Jun; 12(2):197-205. PubMed ID: 1975116
[TBL] [Abstract][Full Text] [Related]
64. [Studies on protective effect of selenium on the nephrotoxicity of cis-diamminedichloroplatinum (CDDP) in mice].
Araya Y
Hokkaido Igaku Zasshi; 1990 May; 65(3):245-53. PubMed ID: 2165995
[TBL] [Abstract][Full Text] [Related]
65. Studies of enzymuria and beta 2-microglobulinuria in patients receiving prophylactic cefotaxime in obstetric and gynaecological surgery.
Ishikawa M; Yamashita K; Shimizu T
Drugs; 1988; 35 Suppl 2():178-80. PubMed ID: 3293974
[TBL] [Abstract][Full Text] [Related]
66. Clinical significance of urinary enzymes in diabetic nephropathy.
Morita E; Kaizu K; Uriu K; Hashimoto O; Komine N; Eto S
J Diabet Complications; 1991; 5(2-3):158-9. PubMed ID: 1685160
[TBL] [Abstract][Full Text] [Related]
67. Urinary beta 2-microglobulin and N-acetyl-beta-D-glucosaminidase (NAG) as early markers of renal tubular dysfunction in sick neonates.
Chen JY; Lee YL; Liu CB
J Formos Med Assoc; 1991 Feb; 90(2):132-7. PubMed ID: 1678405
[TBL] [Abstract][Full Text] [Related]
68. Nephron function in acute glycerol-induced renal insufficiency in rabbits.
Szewczyk Z; Skiba W; Szepietowski T; Rabczyński J
Pol Med Sci Hist Bull (1973); 1975; 15(2):173-81. PubMed ID: 4778
[TBL] [Abstract][Full Text] [Related]
69. [Preventive effect of urinastatin on cisplatin-induced nephrotoxicity].
Kobayashi H; Ishizuka H; Hirashima Y; Ohi H; Demukai H; Moniwa M; Maeda M; Kobayashi T; Terao T; Kawashima Y
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Dec; 41(12):1959-64. PubMed ID: 2592819
[TBL] [Abstract][Full Text] [Related]
70. The excretion of urinary enzymes, proteins and creatinine in patients receiving cisplatinum.
Nekulová M; Mechl Z; Kerpel-Fronius S; Skalková D; Sopková B
Neoplasma; 1987; 34(2):183-8. PubMed ID: 2885765
[TBL] [Abstract][Full Text] [Related]
71. Assessment of renal function during high-dose cis-platinum therapy in patients with ovarian carcinoma.
Buamah PK; Howell A; Whitby H; Harpur ES; Gescher A
Cancer Chemother Pharmacol; 1982; 8(3):281-4. PubMed ID: 6127169
[TBL] [Abstract][Full Text] [Related]
72. Effect of N-N'-diphenyl-p-phenylenediamine pretreatment on urinary enzyme excretion in cisplatin nephrotoxicity in rats.
Gemba M; Fukuishi N; Nakano S
Jpn J Pharmacol; 1988 Jan; 46(1):90-2. PubMed ID: 2896807
[TBL] [Abstract][Full Text] [Related]
73. Renal effects of the non-ionic contrast medium iopentol after intravenous injection in healthy volunteers.
Jakobsen JA; Berg KJ; Waaler A; Andrew E
Acta Radiol; 1990 Jan; 31(1):87-91. PubMed ID: 2187515
[TBL] [Abstract][Full Text] [Related]
74. Diagnostic significance of urinary enzymes for diabetes mellitus and hypertension.
Ishii N; Ogawa Z; Itoh H; Ikenaga H; Saruta T
Enzyme Protein; 1994-1995; 48(3):174-82. PubMed ID: 8589804
[TBL] [Abstract][Full Text] [Related]
75. [The pharmacokinetics of cisplatin and its influence on renal function according to different infusion methods (report II)--alleviation of renal impairment by bismuth subnitrate combined with ginseng and tang-koui ten].
Takahashi A; Takagi M; Hishida H; Sakamoto Y; Takagi N; Amano H; Ogura Y
Gan To Kagaku Ryoho; 1989 Jul; 16(7):2405-10. PubMed ID: 2665654
[TBL] [Abstract][Full Text] [Related]
76. Sex differences in the excretion levels of traditional and novel urinary biomarkers of nephrotoxicity in rats.
Tsuji S; Sugiura M; Tsutsumi S; Yamada H
J Toxicol Sci; 2017; 42(5):615-627. PubMed ID: 28904297
[TBL] [Abstract][Full Text] [Related]
77. The diagnostic value of urinary enzyme measurements in hypertension.
Johnston ID; Jones NF; Scoble JE; Yuen CT; Price RG
Clin Chim Acta; 1983 Oct; 133(3):317-25. PubMed ID: 6414744
[TBL] [Abstract][Full Text] [Related]
78. Urinary endothelin-1-like immunoreactivity in young male patients with testicular cancer treated by cis-platinum: comparison with other urinary parameters.
Takeda M; Komeyama T; Tsutsui T; Mizusawa T; Go H; Hatano A; Tanikawa T
Clin Sci (Lond); 1994 Jun; 86(6):703-7. PubMed ID: 7520380
[TBL] [Abstract][Full Text] [Related]
79. Values for urinary beta 2-microglobulin and N-acetyl-beta-D-glucosaminidase in normal healthy infants.
Nishida M; Kawakatsu H; Komatsu H; Ishiwari K; Tamai M; Tsunamoto K; Kasubuchi Y; Sawada T
Acta Paediatr Jpn; 1998 Oct; 40(5):424-6. PubMed ID: 9821699
[TBL] [Abstract][Full Text] [Related]
80. Urinary excretion of N-acetyl-glucosaminidase and beta-2-microglobulin as early markers of gentamicin nephrotoxicity in neonates.
Gouyon JB; Aujard Y; Abisror A; Laudignon N; d'Athis P; Jacqz E; Biou D; Demelier JF; Mathieu H
Dev Pharmacol Ther; 1987; 10(2):145-52. PubMed ID: 3301233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
